CCL2 and arthritic joint disease: To further validate the mechanism by which MFK902 suppressed arthritis progression, we examined the transcript expression of chemokines (CCL2), adhesion molecules (VCAM-1), MMPs (MMP-1 and -3), and RANKL by semi-quantitative RT-PCR (Fig 5A).